EARLY ACS-(TIMI 39) assessed the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST segment elevation acute coronary syndrome. MAIN RESULTS:Early versus delayed, provisional eptifibatide in acute coronary syndromesN Engl J Med. 2009 May 21;360(21):2176-90. PRESENTATIONS EACS Main Results (ACC 2009)TIMI 39 SlidesMorphine-Clopidogrel Interaction & CV Outcomes in Pts with Non-STEMI … Continue reading EARLY ACS-TIMI 39